Abstract:Core fucosylation (CF) is a special glycosylation pattern of proteins that has a strong relationship with cancer. The Food and Drug Administration (FDA) has approved the core fucosylated alpha-fetoprotein as a biomarker for the early diagnosis of hepatocellular carcinoma (HCC). The technology for identifying core fucosylated proteins has significant practical value. The major method for core fucosylated glycoprotein/glycopeptide analysis is neutral loss-based MS3 scanning under collision-induced dissociation (CID) by ion trap mass spectrometry. However, due to the limited speed and low resolution of the MS3 scan mode, it is difficult to achieve high-throughput, with only dozens of core fucosylated proteins identified in a single run. In this work, we developed a novel strategy for the identification of CF glycopeptides at a large scale, integrating the stepped fragmentation function, one novel feature of quadrupole-orbitrap mass spectrometry, with "glycan diagnostic ion"-based spectrum optimization. By using stepped fragmentation, we were able to obtain both highly accurate glycan and peptide information of a simplified CF glycopeptide in one spectrum. Moreover, the spectrum could be recorded with the same high speed as the conventional MS2 scan. By using the "glycan diagnostic ion"-based spectrum refinement method, the efficiency of the CF glycopeptide discovery was significantly improved. We demonstrated the feasibility and reproducibility of our method by analyzing CF glycoproteomes of mouse liver tissue and HeLa cell samples spiked with standard CF glycoprotein. In total, 1364 and 856 CF glycopeptides belonging to 702 and 449 CF glycoproteins were identified, respectively, within a 78-min gradient analysis, which was approximately a 7-fold increase in the identification efficiency of CF glycopeptides compared to the currently used method. In this work, we took core fucosylated glycopeptides as a practical example to demonstrate the great potential of our novel method for use in glycoproteome analysis, and we also anticipate using the flexible novel method in other research fields.

Characterization of Core-Fucosylated Glycoproteins from Human Normal Liver Tissues

Identification and Analysis of Α1,6‐fucosylated Proteins in Human Normal Liver Tissues by a Target Glycoproteomic Approach

Chemoenzymatic Probes for Detecting and Imaging Fucose-Α(1-2)-galactose Glycan Biomarkers.

Comprehensive Mapping of Protein N-Glycosylation in Human Liver by Combining Hydrophilic Interaction Chromatography and Hydrazide Chemistry

Characterization of Core Fucosylation Via Sequential Enzymatic Treatments of Intact Glycopeptides and Mass Spectrometry Analysis

Core-Fucosylated Glycoproteomics Correlated with the Metastasis of Hepatoma

Site-Specific Analysis of Core and Antenna Fucosylation on Serum Glycoproteins.

A Strategy for Precise and Large Scale Identification of Core Fucosylated Glycoproteins

A precise approach in large scale core-fucosylated glycoprotein identification with low- and high-normalized collision energy.

Integrated Strategy for Large-Scale Investigation on Protein Core Fucosylation Stoichiometry Based on Glycan-Simplification and Paired-Peaks-Extraction

Con A Affinity Glycoproteomics of Normal Human Liver Tissue

Improvement of Core-Fucosylated Glycoproteome Coverage Via Alternating HCD and ETD Fragmentation

Chemoenzymatic Labeling, Detection and Profiling of Core Fucosylation in Live Cells

Identification and Analysis of Altered Alpha 1,6-Fucosylated Glycoproteins Associated with Hepatocellular Carcinoma Metastasis

Strategy integrating stepped fragmentation and glycan diagnostic ion-based spectrum refinement for the identification of core fucosylated glycoproteome using mass spectrometry.

Establishment and Application of a Method for the Detection of the Core Fucosylated IgG Level

Alteration of Liver N-glycome in Patients with Hepatocellular Carcinoma

Discovery of Core-Fucosylated Glycopeptides As Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC- HCD-PRM-MS/MS

Identification of Core-Fucosylated Glycoproteins by Single-Step Truncation of N-Glycans

Alteration of Ck8 Both in Its Expression Level and Its Glycan Parts Related to Hcc Metastatic Ability

Comparative Glycoproteomics Based on Lectins Affinity Capture of N-linked Glycoproteins from Human Chang Liver Cells and MHCC97-H Cells.